Our findings demonstrate that increased GLP1R expression is associated with improved overall survival in certain cancers, such as bladder cancer, breast cancer, esophageal adenocarcinoma, renal clear cell carcinoma, and thyroid carcinoma. Here, GLP1R is linked to cancer.